tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Options
Options Market Overview Unusual Options Activity
Popular
Most Active OptionsOptions Volume Leaders
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement Calculator
New
Mortgage Calculator
Popular
Compound Interest CalculatorStudent Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Tonix Pharma (TNXP)
NASDAQ:TNXP
TNXP
Tonix Pharma
Stock Analysis
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Tonix Pharma (TNXP) Stock News & Sentiment

2,091 Followers
Tonix announces IND clearance by FDA for Phase 2 trial of TNX-2900
The FlyTonix announces IND clearance by FDA for Phase 2 trial of TNX-2900
3d ago
Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in December
Press ReleasesTonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in December
9d ago
Tonix completes clinical stage of Phase 3 RESILIENT study of TNX-102 SL
The FlyTonix completes clinical stage of Phase 3 RESILIENT study of TNX-102 SL
22d ago
Tonix Pharmaceuticals Completes Clinical Stage of Phase 3 RESILIENT Study of TNX-102 SL for the Management of Fibromyalgia
Press ReleasesTonix Pharmaceuticals Completes Clinical Stage of Phase 3 RESILIENT Study of TNX-102 SL for the Management of Fibromyalgia
22d ago
Tonix Pharmaceuticals begins enrollment in Phase 2 bone health study
The FlyTonix Pharmaceuticals begins enrollment in Phase 2 bone health study
24d ago
Tonix Pharmaceuticals Announces Enrollment Initiated in Mass General Brigham Phase 2 Investigator-Initiated Study of TNX-1900 (Intranasal Potentiated Oxytocin) for Bone Health in Children with Autism Spectrum Disorder
Press ReleasesTonix Pharmaceuticals Announces Enrollment Initiated in Mass General Brigham Phase 2 Investigator-Initiated Study of TNX-1900 (Intranasal Potentiated Oxytocin) for Bone Health in Children with Autism Spectrum Disorder
24d ago
Tonix Pharmaceuticals reports Q3 EPS ($1.83), consensus ($1.49)
The FlyTonix Pharmaceuticals reports Q3 EPS ($1.83), consensus ($1.49)
27d ago
More TNXP News >

TNXP News on the Web

TNXP: Topline Results from Phase 3 RESILIENT Study in Fibromyalgia Expected in Late December 2023…
Yahoo Finance
Neutral
Tonix Pharmaceuticals Announces IND Clearance by the FDA for Phase 2 Trial of TNX-2900 for the Treatment of Prader-Willi Syndrome, the Most Common Genetic Cause of Life-Threatening Childhood Obesity
Yahoo Finance
Neutral
Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in December
Yahoo Finance
Neutral
Tonix Pharmaceuticals' CEO reveals next-generation COVID vaccine technology chosen for key program
Yahoo Finance
Neutral
Tonix Pharmaceuticals finish Phase 3 trial of TNX-102 SL for management of Fibromyalgia
Yahoo Finance
Neutral
Tonix Pharmaceuticals Completes Clinical Stage of Phase 3 RESILIENT Study of TNX-102 SL for the Management of Fibromyalgia
Yahoo Finance
Neutral
Tonix Pharmaceuticals Announces Enrollment Initiated in Mass General Brigham Phase 2 Investigator-Initiated Study of TNX-1900 for Bone Health in Children with Autism Spectrum Disorder
Yahoo Finance
Bearish
Tonix Pharmaceuticals’ Vaccine Candidate, TNX-1800, Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
TNXP
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TNXP’s Media Buzz Sentiment?
2 articles about TNXP were published this week. In an average week, 1.75 articles are published.
    What is TNXP’s weekly average amount of articles?
    In an average week, 1.75 articles about TNXP are published.
      What is TNXP’s News Sentiment?
      50% of articles about TNXP were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        REPLReplimune Group
        AMNAMN Healthcare Services
        IMGNImmunoGen
        BCTBriaCell Therapeutics
        EYPTEyePoint Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing